Exam 2 lecture 3 Flashcards

1
Q

Name the gram positive antibiotics

A

Vancomycin
Quinupristine-dalfopristine
Linezolid
Tedizolid
Daptomycin
Telavancin
Dalbavancin
Oritavancin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why has the use of vancommycin increased over the past decades

A

Due to the emergence of MRSA and PRSP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does the large structure of vanc entail

A

Cant be absorbed orally
Cant get into CNS
Does not get removed by hemodialysis membrane

These are common to the otehrs aswell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Vancomycin MOA? bacteriostatic/bactericidal?

A

Inhibits cell wall synthesis at site different than B lactams

It inhibits synthesis and assembly of second stage of cell wall synthesis by binding to D ala D ala on cell wall and preventing cross linking

Time dependent bactericidal activity, slowly kills bacteria (static against enterococcus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How fast/slow is vanc

A

SLOWEST DRUG is vanc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanism of resistance of vanc

A
  1. Resistance in VRE and VRSA is due to modification of D ala D ala binding site of peptidoglycan. D ala replaced by D lactate. Led to loss of critical H bond and loss of antibacterial activity.
  2. VISA (vancomycin intermediate staph aureus)- They had thickened cell wall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the phenotypes that confir resitance to vancomycin (exam)

A

van A is the most important

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Spectrum of activity of vancomycin

A

Gram positive bacteria (aerobes and some anaerobes)
-Streptococcus (group, viridians, pneumonia) including PRSP*
- MRSA* and MSSA*
- C diff* and clostridium spp

  • no activity against gram negatives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What should we use in the case of a serious MSSA infection

A

B lactam (nafcillin/cefazolin)

Only used vanc if we have to bc it is a slow killer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Vanc is THE drug of choice in what disease

A

MRSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are target organisms for vancomycin

A

MRSA, MSSA, PRSP and c diff

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the drug of choice for C diff

A

Vancomycin (oral)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What group does vancomycin show synergy with? Give an example

A

Aminoglycoside synergy

Gentamycin + vanc used together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What formulations does vancomycin come in? How is it used

A

Oral and iV

HORRIBLE oral absorption, but we use this to our advantage to target patients with C diff (collitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Important point to know about distrubution of vancomycin

A

Takes one hour to distrubute form plasma into tissue compartment (take that into account when looking at pak as it will be falseky elevated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is vanc eliminated? half life?

A

Eliminated by kidney

half life depends on renal function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How is hemodialysis going to affect vanc

A

Removed by hemodialysis (30-40% removed per hemodialysis sessions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

When should the peak be drawn for serum concentration in patients on vanc? trough? Target AUC/MIC?

A

60 mins after end of infusion (target 30-40)

Trough- prior to next dose (10-15)

Target AUC/MIC= 400-600

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

clinical uses of vancomycin (exam)

A

infections due to MRSA (THE DRUG OF CHOICE EXAM)

serious gram positive infection in B lactam allergic patients

PRSP (target organism EXAM)

ORAL vancomycin for C diff collitis (EXAM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

adverse effects of vancomycin (exam)

A
  1. Red man syndorme (AKA red neck syndorme)

Related to RATE of IV infusion, no faster than 15 mg per minute

5-15 mins after infusion
Pretreat with antihistamine
We can give it again if we lengethen infusion

  1. Nephrotoxicity and ototoxicity (rare with monotherapy, more common when administered with other nephro/oto agents)
  2. Thrombophlebitis, interstitial nephritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are some risk factors for nephro/ototoxicity with vancomycin (exam)

A

IT is reversible
Risk factors- renal impairement, prolonged therapy, high doses, high serum concentrations, use of other nephro/oto toxic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is synercid a combination of? WHat kind of drug was it?

A

Quinupristine/dalfopristine

It is a streptogramin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What was synercid developed for

A

developed bc of need for antibiotics with activity aganst resistant gram positive bacteria, namely VRE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

ROA synercid? CNS action? Hemodialysis removal

A

TOO big for oral

No CNS

Not removed by hemodualysis membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

MOA of synercid? Where does it bind? Bacteriostatic/cidal?

A

Each agent acts individually on 50S ribosomal unit t inhibit early and late stages of protein synthesis

Binds to 50s ribsosme near site where macrolides and clindamycin bind

bacteriostatic (may be cidal against some bacteria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Mechanism of resistance of synercid

A

alteration in ribsosme binding site
Enzymatic inactivation

27
Q

spectrum of activity of synercid

A

Gram positive bacteria
-ENterococcus Faecium* ONLY
-PRSP*
-MSSA and MRSA
- Coagulase negative staphylococcus

28
Q

What is one of the short comings of synercid

A

ONLY works on VRE enterococcus faecium,
VRE enterococcus Faecallis

29
Q

is synercid time dependent of concentration dependent? Distribution?

A

Time dependent bactericidal

MINIMAL CSF PENETRATION

30
Q

When do we need to adjust synercid

A

Not in renal but in hepatic

31
Q

Clinical use of synercid

A

VRE (faecium) bacterium where we can not use linezolid or daptomycin

32
Q

drug interactions of synercid (exam)

A

3A4 inhibitor

HMG CoA reductase (lovastatin, simvastatin, atorvastatin)

cyclosporin

carbamezapine

33
Q

adverse effects of synercid

A

Venous irritation (only use central vein) (66%)

Myalgias, arthralgias (22%)

34
Q

What are oxazolidinone drugs? ROA?

A

Linezolid and tedizolid

PO and IV

35
Q

What is the reason they developed linezolid

A

needed for antibiotics with activity against resistant gram positives (VRE, MRSA, VISA)

also is effective against enterococcus faecium and Faecalis

36
Q

MOA of linezolid

A

Bind to 50S ribosomal subunit near surface of 30S subunit (unique binding site). Causes inhibition of 70S initiation complex

37
Q

Are oxazolidinones bacteriocidal or bacteriostatic

A

Bacteriostatic (cidal against some)

38
Q

Mechanism of resistance of oxazolidinones

A

Alteration in ribosomal binding site (rare)
Cross resistance with protein synthesis inhibitors is unlikely

39
Q

spectrum of activity of linezolid and tedizolid

A

Gram positive bacteria

Group, viridians and pneumoniae streptococcus (including PRSP)
- enterococcus faecium AND faecalis (including VRE)

- MSSA, MRSA and VRSA*

40
Q

For MSSA, what do we use before linezolid? MRSA?

A

Linezolid is bacteriostatic so we use other drugs before it.
MSSA- nafcillin, cephazolin and Vanc
MRSA- Vancomycin, dapto

41
Q

What are linezolid and tedizolids oral bioavailability? CSF penetration? eliminated by? Renal adjustment?

A

91% tedizolid and 100% linezolid

Linezolid CSF penetration= 30%

Removed renally and non renally

No renal adjustments

removed by HD

42
Q

Clinical use of linezolid/tedizolid

A
  • reserved for serious/complicated infections caused by resistant gram positive bacteria
  • VRE bacteremia or UTI
  • Nosocomial pneumonia due to MRSA and serious infections due to MRSA
43
Q

drug interactions of linezolid and tedizolid

A

Serotonin syndrome with SSRIs/SNRIs

44
Q

adverse effects of linezolid and tedizolid

A

Optic and peripheral neuropathy

Thrombocytopenia or anemia

most often with prolonged tx

45
Q

Name lipopeptide drug? Why was it developed

A

Daptomycin

Developed bc of the need for antibiotics with activity against VRE, MRSA, VISA

46
Q

How big/small is daptomycin? How does this affect the ROA? does it get into CSF? Hemodialysis removal?

A

Huge molecule, not oral

No CSF or HD removal

47
Q

MOA of daptomycin? Time or concentration dependent? Static or cidal?

A

Binds to bacteria and inserts lipophilic tail into cell wall to form trans membrane channel. Causes leak of cellular contents.

Concentration dependent bactericidal activity

48
Q

mechanism of resistance of daptomycin

A

Rarely reported in VRE and MRSA due to altered cell membrane binding

49
Q

spectrum of activity of daptomycin

A

Gram positive
-Group, viridians, pneumo Strep (PRSP)
-Both enterococcus faecium and facialis
(including VRE)
- MSSA, MRSA and VRSA*

50
Q

elimination of daptomycin? Would dosage adjustment be required?

A

Excreted primarily in kidney

Dosage adjustments required in presence of RI

51
Q

clinical uses and dosing of dapotmycin? When should it not be used?

A

Reserved for serious/complicated infections caused by resistant bacteria

6 mg/kg/day

Daptomycin should not be used in tx of pneumonia and left sided endocarditis

52
Q

adverse effects and drug interactions of daptomycin

A

-myopathy and CPK elevation <2%
- Acute eosinophilic pneumonia

Drug i/a
- HMG CoA reductase inhibitors (statin) may lead to increased myopathy

53
Q

Why were lipoglycoeptides developed? What are the drug names?

A

lipoglycopeptides were developed to address the need for antibiotics with activity against VRE, MRSA, VISA

Televancin
Dalbavancin
Oritavancin

54
Q

How big/small are lipoglycopeptides? How does this affect ROA? CSF penetration? HD removal?

A

Huge

Not available orally

Not getting into CSF

Not removed by HD

55
Q

Mechanism of action of lipoglycopeptides? Time/concentration dependent? Bacteriostatic/cidal?

A

All 3 interfere with polymerization and cross linking of peptidoglycan by binding D ala D ala

Televancin and oritavancin can bind to bacterial membranes and insert lipophilic tail to form transmembrane channel. leakage.

COncentration dependent bacteriocidal activity

56
Q

mechanism of resistance of lipoglycopeptides (televancin oritavancin dalbavancin)

A

Alteration in peptidoglycan terminus (oritavancin still maintains activity)

57
Q

Spectrum of activity of lipoglycopeptides

A

Gram positive

  • group, viridians and pneumoniae strep

Enterococcus AND faecalis *

MSSA, MRSA and VISA*

58
Q

Some strains of enterococcus faecalis and faecium are resistant to which lipoglycopeptides

A

televancin and dalbavancin

59
Q

How are lipoglycopeptides eliminated? Which ones need dosage adjustments and which ones dont?

A

Televancin- excreted by kidneys. Dosage adjustment needed

Dalbavancin- 33% unchanged in urine, dosage adjustment needed

Oritavancin- ONLY ONE no adjustment needed

60
Q

clinical uses of lipoglycopeptide

A

serious/complicated infections caused by resistant bacteria

61
Q

What are some interactions lipoglycopeptides have?

A

Televancin and oritavancin interfere with coagulation tests (PT, INR, aPTT) by binding to artificial phospholipid surfaces

62
Q

Adverse effects of lipoglycopeptides? Black box?

A

Televancin- Nephrotoxicity, QTc prolongation, taste disturbances

All- Infusion related rxn (red man)

Televancin black box warning on use during pregnancy.

63
Q

What is drug of choice for unfections due to MRSA

A

Vancomycin